Medical Marijuana Market Size, Share, Growth and Forecast 2018-2026

The latest market report published by Credence Research, Inc., the global market for medical marijuana was valued at US$ 13,908.7 million in 2017 and is expected to reach US$ 57,582.5 million by 2026, increasing to CAGR by 17.1 per cent from 2018 to 2026.

Market Insights

Cannabionoids are natural extracts from Cannabis sativa, Cannabis indica and Cannabis ruderalis. Marijuana has been used extensively for recreation, medical and ritualistic purposes for centuries. It consists of the psychoactive drug component tetrahydrocannabinol which causes the stimulation of the CB1 and CB2 receptors for cannabinoids. Activation of these receptors results in pain management activity in patients suffering from chronic pain due to AIDS, cancer, neuropathic pain, etc. In the last decade marijuana has been a keen research subject for researchers and academicians throughout the globe to understand its therapeutic benefits in treating anorexia and nausea. Positive steps have been taken by healthcare and law enforcing agencies to legalize the production and sale of marijuana for medicinal purpose. Tremendous focus is laid in drafting guidelines for the judicious use of marijuana in healthcare centers. Nowadays marijuana is available as weed infused gums, tampons, cannabinoid infused tea, bath salts, cannabinoid infused coffee and topical balms to get relief from pain.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/medical-marijuana-market

Cancer is currently dominant in the application segment due to the large pool of patients suffering from chronic pain and nausea during chemotherapy. Marijuana was found to be beneficial in the treatment of patients with neurological disorders such as epilepsy, seizures, etc. due to sedative effects. Chronic pain will gain momentum due to an increasing number of patients suffering from musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis and other autoimmune diseases such as psoriasis and multiple sclerosis.

In the present situation, hospital pharmacies dominate the point of sale segment on the basis of key parameters such as low cost availability of medical marijuana and strict monitoring of cancer patients using marijuana for chronic pain treatment. Dispensaries will register good growth during the forecast period due to an increasing number of patients suffering from anorexia and nausea, and will allow the government to deliver marijuana on a regular basis to patients suffering from chronic pain.

North America is the global leader in medical marijuana market owing to the rising prevalence of cancer and proactive policies implemented by USFDA legalizing the production and sale of marijuana for treating chronic pain. Germany has drafted regulatory guidelines for the use of marijuana for medicinal purpose which also serves as a gold standard for other European Union countries. Rest of the World serves as a lucrative market as it is the largest producer of marijuana in the world and regulatory agencies are taking proactive steps to legalize the production and sale of marijuana for therapeutic use.

The key players actively engaged in the production and sale of marijuana are AbbVie, Inc., CannaGrow Holdings, Inc., Canopy Growth Corporation, Inc., GW Pharmaceuticals, Plc. Insys Therapeutics, Inc., Novartis AG, Lexaria Corporation, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and United Cannabis Corporation.

Key Market Movements:

• Rising prevalence of cancer and patients suffering with chronic pain
• Increased research funding for determining the therapeutic efficacy of marijuana for treating anorexia and nausea
• Supportive regulatory environment for the production and sale of marijuana for medicinal purposes

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59334

Table of Content

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
 1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Medical Marijuana Market Portraiture
2.2. Global Medical Marijuana Market, by Application, 2017 (US$ Mn)
2.3. Global Medical Marijuana Market, by Point of Sale, 2017 (US$ Mn)
 2.4. Global Medical Marijuana Market, by Geography, 2017 (US$ Mn)

Chapter 3. Medical Marijuana Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
 3.6. Competitive Analysis: Global Medical Marijuana Market, by Key Players, 2017

Chapter 4. Global Medical Marijuana Market, by Application
4.1. Overview
4.2. Chronic Pain
4.3. Neurological Disorders
4.4. Cancer
 4.5. Others (Anorexia, Nausea etc.)

Chapter 5. Global Medical Marijuana Market, by Point of Sale
5.1. Overview
5.2. Hospital Pharmacy
 5.3. Dispensaries

Chapter 6. Global Medical Marijuana Market, by Geography
 ...........................

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59334

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com